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The continued demand for edible oils by the ever increasing population makes it pertinent to explore 
new sources. In this direction, two new edible oils namely palm oil and rice bran oil have been 
subjected to nutritional and toxicological evaluations of their chemicals constituents. An attempt has 
been made in this article to assess the acceptability of the two oils based on the various investigations 
that have been carried out so far. 
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INTRODUCTION 
 
Vegetable oils are the main source of dietary fat for 
almost all sections of the Indian population and there is a 
continued growing demand from both caterers and con-
sumers. Although the Indian population has a penchant 
for a variety of deep fried products, there is also a greater 
awareness of the problems such as atherosclerosis 
caused by saturated fats. Thus, in view of the present 
health scenario, there is a tendency to replace traditional 
fats like ghee and coconut oil with other healthier options. 
Due to the ever-increasing demand for edible fats, 
several oils and fats are being examined, so as to find a 
fat that is suitable to the Indian consumer. During the 
course of identifying new sources of oil, it is necessary to 
consider its potential to meet both the consumers’ tastes 
as a cooking medium and the essential fatty acid 
requirements. It is also necessary to know the 
atherogenic potential, in view of the fact that consumption 
of saturated fats might lead to cardiovascular disease.  
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Abbreviations: RPO, Red palm oil; CRPO, chemically refined 
palm oil; RBD, refined, bleached and deodorized; PRPO, 
physically refined palm oil; HDL, high density lipoprotein; FER, 
feed efficiency ratio; FFA, free fatty acid; LDP-c, low density 
lipoprotein cholesterol; VLDL-c, very low density lipoprotein 
cholesterol. 
Among the oils under consideration, palm oil and rice 
bran oil offer great scope in India, as they are widely 
preferred by the vanaspathi industries and also by the 
Indian consumer. The oil palm gives higher yields in 
comparison with other oil yielding species. Rice bran oil 
also offers high potential, as India has high rice 
production in the world second only to China. Thus, there 
is an urgent need to evaluate both palm oil and rice bran 
oil under Indian dietary conditions in order to contribute to 
the nutritional and health risks that may follow the 
consumption of these fats in large amounts. 
Many studies have been conducted in relation to 
nutritional status of these edible oils. A large amount of 
information on the ability of these oils to lower cholesterol 
levels, scavenge free radicals, cause mutagenecity and 
other effects. However, there is no paucity of data on: a) 
the effect of feeding them at very high level; b) their 
protective effect on cardiovascular diseases; c) the effect 
of consumption of the fried oil; d) changes in the fatty 
acid composition on heating; and e) their effect on the 
fatty acid composition of plasma, erythrocytes, and other 
tissues. Many trials have been conducted utilizing heated  
palm oil and heated rice bran oil, in both  short  term  and 
long term experimental studies. 
 
 
PALM OIL 
 
The oil-palm tree (Elaeis guineensis) originates  from  the 
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west coast of Africa, where it (oil) has been used since 
very early times (P.O.R.I.M, 1988). The oil palm is 
cultivated widely in East Africa, South America, Indonesia 
and Malaysia. In India, oil palms are now being grown in 
several states (ICAR, 1988). A total area of 5,75,000 ha 
has been identified as suitable for oil-palm cultivation in 
India. The states of Andhra and Karnataka alone grow 
oil-palm over an area of 2,50,000 ha. 
The oil palm plant starts bearing fruits about 5 years 
after planting, reaches its peak production 5 years later 
and continues to yield for another 20 years. The fruit 
consists of a leathery excerpt, a fleshy monocarp and a 
hard shell called endocarp. The endocarp contains a 
creamy endosperm (Cottrell, 1991). Palm oil obtained 
from the monocarp of the oil-palm fruit. The oil is 
extracted from the mesocarp of the oil-palm fruit by a 
series of unit operations involving; (1) sterilization of palm 
fruits for arresting the lipase enzyme present; (2) 
stripping for separating the fruits from the bunch; (3) 
screw pressing; (4) separation of the oil and its clarify-
cation. The palm kernel oil is obtained from another set of 
unit operations. These operations are seed separation, 
shell cracking, shell separation, kernel crushing, and 
screw pressing and solvent extraction. The oil obtained 
by the above method is called crude palm oil and red 
palm oil because of its intense orange color. The red 
palm oil is an unrefined, unbleached version and 
extremely rich in carotenoids. The total carotenoids 
content of red palm oil is said to vary from 500-1600 ppm 
(Wong et al., 1988). α-Carotene (29%), β-carotene 
(62%), γ-carotene (4%), Xanthophylls and Lycopene 
(2%) which contribute to the red color. RPO is the only 
vegetable oil that contains carotenoids of which 62-70% 
is beta-carotene. Beta-carotene is the most common 
precursor of vitamin A, which is important for maintaining 
the skin and mucous membranes in good condition, as 
well as in promoting good vision, bone growth and repro-
duction. Another aspect of the RPO is the phospholipid 
content. The phospholipid content of crude palm oil 
varies with the season and to a lesser extent with the mill 
operation. Red palm oil contains 3.2-4.5 ppm iron. 
Recent studies indicate that beta-carotene acts as an 
anticarcinogen, (Sylvester et al., 1986), and produce a 
hypocholesterolemic effect (Shaish et al., 1995) in 
conjunction with other favourable factors. In fact, 1 g of 
RPO contains 430-760 IU of vitamin A. However, there 
are hardly any reports to show the extent of change in 
carotenoid contents in red palm oil (RPO) kept for a long 
time under storage. 
RPO also contains about 1.5% of unsaponifiable 
matter, which includes sterols, tocols (tocopherol and 
tocotrienols) and the carotenes. During the process of 
refining, most of the carotenes are lost, thereby 
increasing the cost of the oil. In view of this, attempts are 
now being made to make use of the red palm oil as a 
source of vitamin A to meet the needs of Indian popula-
tion particularly children, to prevent vitamin  A  deficiency.  
 
 
 
 
The technology for retaining most of the β-carotene in 
RPO has been developed (Rajam et al., 2005; Manorama 
and Rukmini, 1992). The unsaponifiable fraction of the 
RPO also contains, Tocopherol (20%), tocotrienols (25%) 
α-tocotrienols (45%) and γ-tocotrienols (10%). In palm oil, 
the later compounds vary from 600-1200 ppm. The 
tocopherols are not only good antioxidant; they are also 
physiologically active as vitamin E. In addition to 
tocopherols, one finds in palm oil tocotrienols which 
constitute two – thirds of the total tocols that are present 
(Cottrell, 1991). Tocopherols and tocotrienols are known 
to scavenge free radicals (Packer, 1992), protect against 
oxidative injury (Serbinova et al., 1992), reduce platelet 
aggregation (Qureshi et al., 1991), and protect against 
atherogenesis (Hasselwander et al., 2002) and cancer. 
In India 90% of the palm oil produced is used for edible 
purposes. To meet the growing demand for oil, India also 
imports RBD (Refined, Bleached and Deodorized) oil. 
The RBD palm oil has a pale yellow color like other 
refined oils and is semisolid at room temperature; it has a 
good shelf life (Cottrell, 1991). Under normal conditions, 
palm oil is usually a semi-solid, in the tropics, but at 
colder temperatures it is a solid fat. The solid consistency 
makes the palm oil less acceptable as cooking oil in cold 
countries. The process of fractionation by cooling leads to 
the formation of high-melting triglycerides (palm stearin) 
leaving behind low-melting glycerides (palm olein). Palm 
olein is therefore the liquid fraction of palm oil. There is 
also a difference in fatty acid composition of palm olein 
and palm stearin (Table 1); palm stearin is characterized 
by a low P/S ratio, and is more saturated than palm olein. 
In countries like Japan, refined palm oil is further 
refined through treatment with phosphoric acid, followed 
by de-acidification with alkali, bleaching and deodoriza-
tion, before being available commercially. Such refined 
palm oil is called chemically refined palm oil (CRPO). The 
CRPO has a lower free fatty acid content than the 
physically refined palm oil (PRPO) (Miyazawa et al., 
1994). The quantity of palm oil refined by these two 
methods is commonly judged by chemical and physical 
criteria (Swoboda, 1985; Williams and Padley, 1985). The 
physically refined and chemically refined palm oil has 
certain physico-chemical properties which are absent in 
imported oil (Table 2). CRPO does not seem to be 
nutritionally superior to the physically refined palm oil, as 
both these oils produce similar rates of growth in rats. 
However, chemical refining does not reduce the free fatty 
acids to lower levels than physical refining (Duff, 1991; 
Young et al., 1986). 
Palm oil is widely used in domestic cooking and for the 
production of vanaspathi and margarine, for which 
purpose it is blended with other oil. It can easily substitute 
conventional vegetable oil, like peanut and coconut oils for 
domestic use, and make the latter available for other 
purposes. Moreover, the β-carotene present in the oil can 
also function as a natural color for margarines. Palm oil is 
also widely used in coffee whiteners, and in confectionery  
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Table 1. Physico-chemical properties of the palm oil. 
 
Palm oil            Physically refined palm oil             (PRPO) 
Chemically refined palm oil 
(CRPO) 
Iodine value (meq /kg)             50.4 50.2 
Acid value (meq/kg)                  0.7 0.1 
Peroxide value (meq/kg)           4.9 0.9 
Carbonyl value (meq/kg)          34.5 25.7 
 
Source: Ramachandran (2001). 
 
 
 
Table 2. Major components of crude red palm oil. 
 
Components ppm 
Carotenoids 500-700 
Tocopherols and Tocotrienols 600-1000 
Sterols 329-530 
Phospholipids 5-130 
Triterpene alcohols 40-80 
 Methyl sterols 40-80 
Squalene 14-15 
Aliphatic alcohols 100-200 
Aliphatic hydrocarbons 50 
 
Source:  Food and Nutrition Bulletin (1994). 
 
 
 
as a substitute for cocoa butter. 
Palm oil, and its fraction-palm olein and palm stearin – 
are gaining its importance in the food industry (Palm oil 
update, 1989). Palm stearin is used instead of beef tallow 
for the manufacture of margarines (Bhattacharyya et al., 
1987), palm olein is used in the manufacture of 
vanaspathi, hydrogenated vegetable oil; moreover, it is 
being incorporated into confectionery, bakery products, 
ice creams, and coffee whiteners. In India, it is used as a 
substitute for cocoa butter, and thus helping in reduction 
of import of cocoa butter. 
The major objection to the use of palm oil has been that 
it is a saturated fat. Some earlier studies (Anderson et al., 
1976) indicated that palm oil could increase cholesterol 
levels, and thus considered worse than animal fat, mainly 
due to the growing concern over the relationship between 
atherosclerosis and high cholesterol levels. However, 
several years later studies by various workers, Hornstra 
(1987), Horlick and Craig (1957) and Gottenbos and Vles 
(1983) indicated that palm oil is hypocholesteremic, 
increases protective High density lipoprotein (HDL), and 
does not cause atherogenesis, in spite of its low P/S ratio 
(0.31) and low linoleic acid content (10%). Animal 
experiments have shown that Palm oil is similar to other 
oils in absorption, feed efficiency ratio (FER) and growth 
promotion (Baudet et al., 1984; Khan and Lim, 1988). 
Further, it prevents cholesterol accumulation in the liver 
of young and adult rats  (Choi  et  al.,  1993)  even  in  the 
liver of hyper cholesterolemic animals. In humans, it not 
only decreases cholesterol, (Hornstra, 1988), but also 
increases HDL and decreases apo-B, relative to the 
control diets (Sundaram et al., 1990). Subsequent studies 
by various workers have unequivocally demonstrated that 
palm oil though low in linoleate content, is not 
hypercholesterolemic because of: (a) the equal distri-
bution of saturated and unsaturated fatty acids in it, and 
(b) the high content of oleic acid (18:1, n-9) which has 
been proved to reduce cholesterol levels (Khor and Tan, 
1992; Mattson and Grundy, 1985; Rudel et al., 1991). 
The level of linoleate is just optimum in this fat, as higher 
levels are preferred due to the possible generation of free 
radicals and the oxidation unsaturated fatty acids, which 
can probably lead to various forms of cancer and tumor 
(Conte et al., 2004). 
Recent studies by Japanese workers indicated that 
feeding palm oil alone induces a deficiency of n-3 fatty 
acids leading to the accumulation of eicosapentaenoic 
acid (EPA 22:5, n-6) (Rebhung et al., 1994). The 
increase in 22:5, n-6 is compensated by the decrease in 
docosahexaenoic acid (DHA: 22:6, n-3). It has been 
shown that, this could be prevented by feeding an 
optimum level of n-3 fatty acid containing vegetable oil 
like soybean oil (Miyazawa et al., 1994). It is obvious 
from the above studies that the nutritional qualities of 
fatty acids cannot be judged solely by their fatty acid 
composition. 
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Crude palm oil contains a variety of minor components, 
which play a major role in lowering cholesterol levels, and 
providing protection against tumor development (Goh et 
al., 1994; Engelberts et al., 1993). Technologies are 
being developed to retain the β-carotene in palm oil. The 
β-carotenes present in the crude palm oil are being 
exploited as a source of vitamin A, particularly in 
countries where the vitamin A deficiency is wide spread 
(Gopalan et al., 1992). β-Carotene of palm oil has a 
protective effect against cancer (Sundaram et al., 1989). 
It contracts any arterial thrombosis tendency and aggre-
gation of platelets due to the presence of tocopherols and 
tocotrienols. It also protects against X-ray include 
damage in bone marrow cells and prevents peroxidation 
of skin lipids (Rand et al., 1988). 
Crude palm oil did not prove toxic to rats, and did not 
alter their reproductive performance, when fed at low 
levels for several generations (Manorama et al., 1993). 
No deleterious effects were observed when high protein 
diets, containing 10% of heated palm oil, were fed to rats 
for a short duration (Okiy and Oke, 1986). Palm oil has 
also been found be non-toxic, antimutagenic and 
anticarcinogenic (Azuine et al., 1992). Thus, the above 
studies indicate that palm oil is safe for human 
consumption at low levels. If the cost of palm oil is 
maintained at a reasonable price, one could ensure a 
higher level of consumption, among poor income groups 
and thus reduce calorie and vitamin A deficiencies. It 
could also help in preventing atherosclerosis, and also 
increase the intake of beneficial components like β-
carotene, tocopherols and tocotrienols. 
Further studies need to be carried out on blending 
(Hariharan et al., 1996) oils, with the following objectives: 
a) to increase n-3 fatty acids; b) to evaluate the 
simultaneous increase of saturated fatty acids like 
palmitic (16:0) acid; and c) its effect of blending on 
linoleic acid acid levels. By blending of oil, it should 
become possible to favorably shift the n-6 /n-3 ratio close 
to the recommended levels (Ghafoorunissa, 1994). Palm 
oil as such does not contain any trans-fatty acids. 
However, further elaborate investigations are needed to 
see whether heating of palm oil leads to the formation of 
trans- isomers. 
 
 
RICE BRAN OIL 
 
Rice is produced in very large quantities in nine countries 
of South-east Asia. Considerable amounts are also 
produced in the USA, Europe and Latin America. China is 
the largest rice producing country followed by India. Rice 
bran is a byproduct of rice processing industry and upon 
extraction yields rice bran oil. The oil content of rice bran 
varies in each variety, and depends to an even greater 
extent on the processes and conditions obtained during 
rice milling. Rice bran, as such, has 15 to 25% of oil 
associated with  it.  The  total  world  production  of  about  
 
 
 
 
4000 million tons of paddy may yield about 6-7 million 
tons of edible grade oil. Modern techniques of recovery 
would yield oil and other by-products of better quality 
than the old technologies, still being used in India, China 
and other Asian countries.  
Rice bran oil is comparatively new oil, recently 
introduced in the consumer market. It is used in the 
manufacture of vanaspathi and for culinary purposes. 
Rice bran oil shows great promise for extensive use in 
India, due to the presence of several factors like γ-
oryzanol, which are known to protect from cardiovascular 
diseases. Multiple generation studies are being 
conducted to evaluate its nutritional quality, mutagenicity 
and protective effect against certain types of cancer. 
There are a number of factors that influence the quality 
of rice bran oil. Immediate extraction and processing are 
considered as of prime importance, as delayed extraction 
can lead to problems, such as color changes and 
deterioration of organoleptic quality and flavours. More-
over, rice bran quality is also influenced by the presence 
of an active lipase, which hydrolyses the triglyceride to 
fatty acids and glycerol. The rate of hydrolysis is so high 
that the free fatty acid (FFA) content in the oil may rise by 
10-20% within a day and up to 70% in a month, imparting 
a dark colour to the oil. The composition of oil is known to 
vary with respect of phospholipids, glycolipids and non-
glyceride components such as waxes, sterols, oryzanols 
(ferulic acid esters) tocopherols, hydrocarbons, besides 
pigments and odour components (Sharma and Rukmini, 
1987). 
Commonly, rice bran oils having an FFA content of 15-
40% are produced. Commercial rice bran oil varies in 
FFA depending on the quality of rice bran from which the 
oil has been extracted. The refining of high FFA oil has 
been accomplished by different methods such as 
physical refining (Rao, 1983), Bhattacharya et al. (1987) 
using simple solvents like hexane, or with mixtures of two 
solvents like hexane and ethyl alcohol, or of ethyl alcohol 
and isopropanol. Rice bran oil is more difficult to refine 
using methods like alkali or heat treatment, due to the 
presence of tightly associated wax. Hence, the oil has to 
be dewaxed and degummed before being neutralized. 
De-waxing is done by treating with hexane or other 
solvents and removing the separated wax by filtration or 
centrifugation. Thereafter, the oil has to be degummed. 
The earliest method employed for degummed of rice bran 
oil involved the use of 0.1 M phosphoric acid 
(Bhattacharya and Bhattacharya, 1985) of 85% strength, 
in the form of a 10% aqueous solution, at 60% for 30 min. 
The degummed oil may be de-waxed again by treatment 
with 0.2% calcium chloride, in the form of 10% aqueous 
solution, at 15°C for 4 h (Bhattacharyya and 
Bhattacharyya, 1983). Current commercial practices 
involve de-waxing and degumming by adding phosphoric 
or citric acids followed by filtration or settling. Alterna-
tively, steam is passed into the oil at a temperature of 80-
100°C, which separates the gum  by  flocculation  (mutual  
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Table 3. Characteristics of crude and refined Bran oil. 
 
Characteristic Crude Bran oil Refined Bran oil 
Free fatty acids (%) 30 0.1 
Unsaponifiable matter (%) 4 2.0 
Refractive Index 1.46-1.47 1.46-1.47 
Specific gravity  0.91-0.92 0.91-0.92 
Iodine value 85-105 90-105 
Saponification value 175-195 180-195 
Acid value 80.0 0.5 
Flash point Pensky martens 90 250 
 
Source: Ramachandran (2001). 
 
 
 
adhesion and floating). Subsequently the oil is de-
acidified by steam distillation to remove the free fatty 
acids, or also by physical refining e.g., distillation or mis-
cellar refining. Efforts have also been made to deacidify 
rice bran oil by re-esterification using a chemical catalyst 
(Bhattacharyya and Bhattacharyya, 1987). The oil 
obtained is then bleached, using activated carbon, and 
the deodorized to get pure rice bran oil. The unsaponi-
fiable fraction obtained during refining contains vitamin E, 
tocopherols and oryzanol, all of which have various 
pharmaceutical properties. The refined rice bran oil thus 
produced has a characteristic colour and the 
characteristics as listed in Table 3. 
The total availability of rice bran oil in India is about 6 
million tons (Usha and Premi, 2011). The present 
production of rice bran oil is about 400,000 tons of which 
only 50% is of edible grade, 50% of the total available 
rice bran oil is left unutilized due to various reasons. 
About 40% of rice milling capacity in India is provided by 
obsolete huller type mills (Seth and Mehta, 1987). Thus, 
if hullers are eliminated from commercial rice milling, and 
replaced at least 1-2 million tones of additional bran 
would become available for extraction. The other major 
problem affecting the quality of bran is the presence of a 
powerful lipase (Guptha, 1989). Several methods have 
been developed to stabilize the rice bran by de-activating 
this enzyme (Desikachar, 1974; Maharaj, 1982). A newer 
bran stabilization technique–viz., the low-cost acid 
stabilization technique could obviate problems arising 
from presence of non-oil impurities like wax, unsaponified 
matter, color pigments in bran handling (Gopalakrishna, 
2002). These impurities restrict the use of rice bran oil in 
the manufacture of vanaspathi.  Most of the vanaspathi 
manufactures in India do not use more than 20-30% of 
rice bran oil for vanaspathi manufacturing, mainly due to 
the high content of color and unsaponifiable compounds 
in the final product. In 1994-95, about 150,000 tons of 
rice bran oil was used for vanaspathi manufacture. 
India is one of the largest producers of rice, and thus 
has a high potential to produce rice bran oil. The rice 
bran contains 15-20% of oil by weight (4.2%) which is 
rich   in   constituents   such   as   phytosterols,  triterpene 
alcohols, tocopherols, tocotrienols (Sharma and Rukmini, 
1987). It also has a highly hypocholesteremic compound, 
viz., γ-oryzanol (1.6%), which is a mixture of ferulic acid 
esters of sterols and triterpene alcohols, for example, 
cycloartanol, 106 mg/dl; cycloartenol, 482 mg/dl and 24-
methylene cycloartanol, 494 mg/dl (Itoh et al., 1973). The 
tocotrienols and tocopherols act as antioxidants, and thus 
provide oxidative stability to the fat (Lea, 1960). The 
triglyceride fatty acid composition is similar to that of 
other oils with a high concentration of linoleic acid (35-
38%) and α-linolenic acid ranging from 1.8-2.4%. 
Besides, it has also some squalene, which is beneficial 
for the skin. As against this, the commercially obtained oil 
varies in FFA content depending on the quality of rice 
bran from which it has been extracted. The FFA content 
of refined oil varies from 2-5%, whereas crude oils with 
high FFA content ranging from 15-40% are also pro-
duced. This is due to the presence of a lipase in the bran, 
which should normally be inactivated before extraction of 
oil. Some methods have already been developed to 
inactive the enzyme (Gopalakrishna, 2002). The oil thus 
produced, is clear in colour and is widely used as a 
cooking medium in Japan, Korea, China, and to some 
extent in India and South-East Asian countries.  
 
 
NUTRITIONAL AND TOXICOLOGICAL STUDIES ON 
RICE BRAN OIL  
 
Several studies have indicated that consumption of rice 
bran oil has no adverse effect with respect to absorption, 
utilization and growth promotion in rats (Sharma and 
Rukmini, 1986; Seetharamaiah and Chandrasekhara, 
1989a). Similar results were obtained with hamsters 
(Kahlon et al., 1992) and also in non-human primates. In 
the latter, the total cholesterol, LDL-c and apo B levels 
were also reduced (Nicolosi et al., 1991). Besides 
multigeneration studies have been completed in rats that 
were fed rice bran oil at 10% level to evaluate the 
toxicological effect (Rukmini, 1980) and reproductive 
performance, vis-à-vis peanut oil, as judged by the 
percentages   of   consumption,   birth  weight,  litter  size,  
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weaning weight and pre-wearing mortality. Further, no 
mutagenic and teratogenic effects were observed and so 
its safety for human consumption could be established, 
using the food safety protocol of the WHO/Food Safety 
Council (WHO Report, 1987; SCFSC, 1978). 
Further studies with rice bran oil were conducted to 
evaluate its hypocholesteremic effect in a diet containing 
added cholesterol (Rukmini and Raghuram, 1991). The 
results were evaluated and rice bran oil was found to be 
highly hypocholesteremic (Sharma and Rukmini, 1986; 
Purushothama et al., 1995). Notable reduction in total 
cholesterol, low density lipoprotein cholesterol and very 
low density lipoprotein cholesterol, reduction of liver 
cholesterol and triglyceride levels and fecal excretion of 
sterols were observed. These observations suggest that 
RBO increases the turnover of cholesterol 
(Seetharamaiah and Chandrasekhara, 1989b). Substitu-
tion of varying amounts of rice bran oil in place of palm, 
peanut and coconut oil also resulted in significant 
reduction of total cholesterol and triglyceride concen-
tration in humans (Raghuram et al., 1989; Raghuram and 
Rukmini, 1995). Cholesterol lowering effect was observed 
also in monkeys fed a diet with rice bran oil (Nicolosi et 
al., 1991). In studies on humans, significant reduction 
was observed in plasma cholesterol, when replaced with 
RBO in hyperlipidaemic patients (Lichtenstein et al., 
1994). In all the cases, the diet was able to induce 
hypocholesteremia, resulting from a selective decrease of 
LDL-c fraction. Besides, the hypocholesteremic effect of 
RBO was greater than what could be predicted from fatty 
acid composition. This discrepancy might be explained by 
the relatively high concentration of unsaponifiable com-
pounds- including plant sterols, oryzanol and tocotrienols- 
in rice bran oil, when compared to other vegetable oils. 
Various workers have shown that the unsaponifiable 
fraction in rice bran oil has γ-oryzanol (Scavariello and 
Arellano, 1998). It has been suggested that these 
compounds can act as regulatory agents, which control 
cholesterol biosynthesis by regulating certain key 
enzymes (Rong et al., 1997). Oryzanol is a mixture of 
ferulic acid esters of tripenoids alcohol. Apart from its 
hypocholesterolemic activity, oryzanol also promotes 
growth in animals and maintains the estrous cycle in rats 
(Shojiro and Shvetzu, 1980; Shimomura et al., 1980). 
Feeding diets containing oryzanol at 0.5% level, for about 
7 weeks, reduces the total cholesterol, triglycerides and 
LDL-c, respectively (Seetharamaiah and 
Chandrashekhara, 1998) and protects against platelet 
aggregation (Seetharamaiah et al., 1990). Besides, it also 
reduces triglyceride levels in rats having fructose induced 
hypertriglyceridaemia in rats (Seetharamiah and 
Chandrashekhara, 1988). Further, it possesses a 
potential antioxidant effect, and protects against lipid 
peroxides. 
Several evidences suggest that cycloartenol, a 
triterpene alcohol is observed, and accumulates in liver 
(Kiribuchi et al.,  1983).  Since  its  structure  is  similar  to  
 
 
 
 
cholesterol, this compound competes for the cholesterol 
binding sites and thereby causes metabolism and 
excretion of cholesterol as bile salts and pigments. 
Besides, tocotrienols are also reported to inhibit the HMG 
CoA reductase activity of the biosynthetic pathway of 
cholesterol (Qureshi et al., 2002; Hirose et al., 1991; 
Sugano and Tsuji, 1997). Furthermore, triterpene also 
inhibits esterase activity leading to slow hydrolysis of 
cholesterol esters which leads delay in absorption of 
cholesterol. 
It has been demonstrated that rice bran oil (both heated 
and unheated) possesses anti- and non- mutagenic 
activity (Polasa and Rukmini, 1987). Oils heated in a 
domestic kitchen are normally non heat abused. However 
in a restaurant where the oil is heated for a prolonged 
period in the presence of oxygen and moisture: conse-
quently, its mutagenic potential may increase. Thus, rice 
bran oil is highly protective against hypercholesteremia, 
hyperlipidemia and coronary heart disease. Moreover, 
the PUFA/SFA ratio and linoleic/α-linolenic ratio of RBO 
is nearly similar when compared with the recommen-
dations of the world health organization (WHO Report, 
1990). Hence, its use has been recommended in 
moderate amounts. 
Since RBO has several (Sugano et al., 1999) 
advantages and health protecting effects, necessary 
steps should be taken to enhance its production and 
consumption. Further studies are required to evaluate the 
blending (Sunitha et al., 1997) with other oils to increase 
the production and thereby make large quantities of this 
non-conventional oil available for human consumption 
(Sugana and Tsuji, 1996). Further studies should be 
oriented toward the formulation of infant foods containing 
palm oil and rice bran oil, - in order to utilize the beneficial 
advantages they can confer, not only by decreasing 
cholesterol levels, - but also as good sources of vitamin A 
and oryzanol, respectively. 
 
 
FUTURE PROSPECTS 
 
Studies indicate that palm oil is safe for human 
consumption.  If the cost of palm oil is reduced, one could 
ensure a higher level of consumption, among poor 
income groups and thus reduce calorie and Vitamin A 
deficiencies. Further studies need to be done on blending 
of oils (Hariharan et al., 1996), with the following 
objectives: a) to increase n-3 fatty acids; (b) to evaluate 
the simultaneous increase of saturated acids like palmitic 
(16:0) acid; and (c) effect of blending on linoleic acid 
levels.- By blending of oils, it should become possible to 
favorably shift the n-6/n-3 ratio close to the 
recommended levels (Ghafoorunissa, 1994), palm oil as 
such does not contain  any  trans  fatty  acids.   However, 
further elaborate investigations are needed to see 
whether heating of palm oil leads to the formation of trans 
isomers, given  the  low  rate  of  oil  consumption  by  the  
  
 
 
Indian population, on increase in palm oil consumption is 
unlikely to have any adverse effect; on the other hand, it 
could help to prevent atherosclerosis, and also increase 
the intake of beneficial components like β-carotene, 
tocopherols and tocotrienols. 
Rice bran oil also has several advantages (Sugano et 
al., 1999), and health protecting effects. Necessary steps 
should be taken to enhance its production and to 
popularize its consumption.  Further studies are required 
to evaluate the blending with other oils (Sunitha et al., 
1997) to increase the production, and there by make 
large quantities of this non-conventional oil available for 
human consumption (Sugana and Tsuji, 1996). 
This knowledge would be useful in recommending 
various ways of using these oils in food industry, as well 
as in house holds. 
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